Caribou Biosciences (CRBU) reported better-than-expected earnings in the first quarter, with top and bottom-line beats.
Decades of data following the migratory patterns of endangered caribou show that migration areas have decreased significantly ...
March 10, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company BERKELEY, Calif., Feb. 18, 2025 (GLOBE ...
Caribou residents could pay higher property taxes if more isn’t cut from proposed 2025 expenses. City councilors discussed a potential $1.2 million shortfall in revenues that could mean raising the ...
CB-010 ANTLER 2L LBCL and CB-011 CaMMouflage r/r MM Phase 1 clinical data expected in H1 2025 ---- Advancing four clinical programs for ...
7d
Zacks Investment Research on MSNCaribou Biosciences, Inc. (CRBU) Reports Q4 Loss, Lags Revenue EstimatesCaribou Biosciences, Inc. (CRBU) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.39 per share a year ago. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results